Information Journal Paper
APA:
Copy. (2019). NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML. BLOOD, 133(21), 0-0. SID. https://sid.ir/paper/1027713/en
Vancouver:
Copy. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML. BLOOD[Internet]. 2019;133(21):0-0. Available from: https://sid.ir/paper/1027713/en
IEEE:
Copy, “NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML,” BLOOD, vol. 133, no. 21, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/1027713/en